Skip to main content
Premium Trial:

Request an Annual Quote

Egyptian Biotech Group Seeks 'Omics Partners

NEW YORK (GenomeWeb News) – The Egyptian Organization for Biotechnology and Vaccines is seeking partners to work with it on a variety of research program areas focused largely on genotyping and pharmacogenetics in cancer and in autoimmune diseases, the European Commission said this week.

The Cairo-based lab seeks partners for collaborative projects of small, medium, and large scales that could involve a range of research areas.

These projects could involve research into pharmacogenomics and pharmacogenetics research; bioinformatics; epigenetic applications in gene therapy for autoimmune diseases; epigenetic applications in gene therapy for autoimmune disease; human molecular diseases that could include DNA-based technologies; developing real-time PCR for quantifying gene expression related to diabetes, cancer, and leukemia; and proteomics and metabolomics applications of disease treatment, among others.

More information about the partnership request is available at the European Commission’s Seventh Framework Program website.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.